SNA02-48

N/A

Report date: 2025/06/05 15:14:09

Base Information

Drug NameSNA02-48
Drug Alias NameSNA02-48SNA0248
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionTetanus toxin inhibitors
TargetsTetanus toxin
Therapy Area/IndicationsTetanus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSinovac Life Sciences Co LtdSynermore Biologics (Suzhou) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSynermore Biologics (Suzhou) Co LtdSinovac Life Sciences Co Ltd
Inactive CompaniesN/A
Active IndicationsTetanus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A